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Abstract 
Hypoxia-induced reactive oxygen species (ROS)-mediated expression of a variety of 
genes in endothelial cells has been suggested to be involved in abnormal cell adhesion. 
To prevent this by accelerated binding of catalase to endothelial cells, human catalase 
(hCAT), an enzyme catalyzing the decomposition of hydrogen peroxide, was fused with 
three repeats of arginine-glycine-aspartic acid peptide or nona arginine peptide at the 
C-terminal to obtain hCAT-(RGD)3 and hCAT-R9, respectively. Human CAT and its 
derivatives were expressed in yeast Pichia pastoris and purified. The specific activity 
and secondary structure of hCAT-(RGD)3 and hCAT-R9 were close to those of hCAT, 
but these derivatives showed higher binding to mouse aortic vascular endothelial cell 
line MAEC than hCAT, indicating that they are cytophilic derivatives. Hypoxic 
treatment of MAEC increased the intracellular ROS level, the binding of mouse 
melanoma cells, and the activity of transcription factors, hypoxia inducible factor-1 and 
nuclear factor-κB. hCAT-(RGD)3 or hCAT-R9 efficiently inhibited these changes 
compared with hCAT. These results indicate that cytophilic hCAT-(RGD)3 and 
hCAT-R9 are effective in inhibiting hypoxia-induced tumor cell adhesion to endothelial 
cells. 
 
Keywords: recombinant human catalase; abnormal cell adhesion; reactive oxygen 
species; hypoxia; free radicals 
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Introduction 
Vascular endothelium is a monolayer lining the interior surface of blood vessels, which 
forms an interface between blood and tissue. Dynamically responding to changes in 
environmental factors, such as oxygen tension, cytokines and growth factors, 
endothelial cells play a pivotal role in maintaining physiological homeostasis [1]. 
Abnormal cell adhesion to vascular endothelium is observed in a wide range of 
pathological situations, including arteriosclerosis, thrombosis and tumor metastasis 
[2-4]. Under these pathological conditions, local blood flow is impaired to induce 
microenvironmental changes that lead to the imbalance of oxygen demand and supply, 
and resulting hypoxia [5]. Endothelium that has experienced hypoxia can be the ‘soil’ 
for tumor metastasis, because cells, including endothelial cells, increase the 
transcription of a variety of genes for adaptation to hypoxia [4]. An increasing body of 
evidence suggests that ROS play a central role in controlling hypoxia-induced 
transcription [6, 7]. Therefore, eliminating ROS in endothelial cells can be an efficient 
approach to controlling abnormal cell adhesion to endothelium. Catalase is an 
antioxidant enzyme that catalyzes the degradation of hydrogen peroxide, ROS with a 
long half-life. However, previous studies have demonstrated that catalase poorly 
interacts with cells [8], so that any approaches to increasing its binding to cells could 
increase its therapeutic potential in a wide range of disease conditions. 
A variety of molecules, including integrins and other adhesion molecules, are 
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expressed on the surface of endothelial cells [9]. In addition, negative charge of cell 
surface provides a vast surface area for binding of cationic compounds [9]. In this study, 
two types of cytophilic human catalase (hCAT) derivatives were newly designed: one is 
hCAT fused with a arginine-glycine-aspartic acid (RGD) peptide, which is a 
well-known ligand for αvβ3 integrin, and the other is one fused with a nona arginine 
(R9) peptide, a cationic peptide. hCAT and its derivatives were expressed in P. pastoris, 
and their activity to inhibit hypoxia-induced tumor cell adhesion was examined. 
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Materials and Methods 
Cell culture 
A mouse aortic vascular endothelial cell line (MAEC), a gift from Professor Ichiro Saito 
(Department of Pathology, Tsurumi University School of Dental Medicine, Yokohama, 
Japan), was cultured as previously reported [10]. B16-BL6/Luc [11] and colon26/Luc 
[12], clones of murine melanoma B16-BL6 and murine colon carcinoma colon26 that 
stably express the firefly luciferase, were grown as reported previously. A murine Lewis 
lung cancer (LLC) was cultured as reported previously [13]. To establish LLC/Luc, 
LLC was transfected with pCMV-Luc [14] using Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA, USA) according to the manufacturer’s instruction. Cell culture under 
hypoxic conditions (8 % oxygen) was carried out using an AnaeroPack (Mitsubishi Gas 
Chemical Co., Tokyo, Japan).  
 
Expression and purification of recombinant human catalase derivatives 
The pCMV6-Entry vector containing the genomic Homo sapiens catalase (NM_001752) 
cDNA was purchased from OriGene Technologies Inc. (Rockville, MD, USA). 
Oligonucleotides corresponding to the amino acid sequence RGDRGDRGD 
(5’-AGAGGTGATAGAGGCGACAGAGGTGAC-3’) or RRRRRRRRR 
(5’-AGAAGAAGGAGAAGAAGGAGAAGGAGA-3’) were purchased from Greiner 
Bio-One Co. Ltd. (Tokyo, Japan). For the expression of glutathione S-transferase 
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(GST)-fusion proteins in the cytoplasm of P. pastoris, pNT401 vector was first 
constructed from pIB2 vector [15]; DNA sequence encoding GST was PCR-amplified 
and cloned immediately downstream of glyceraldehyde-3-phosphate dehydrogenase 
promoter within the parental vector. A PCR fragment of human catalase cDNA was 
digested with BglII and XbaI and inserted into BamHI-SpeI site of pNT401 expression 
vector. To construct plasmid vectors expressing hCAT-(RGD)3 or hCAT-R9, the DNA 
sequence corresponding to the C-terminal 11 amino acid residues (SHLAAREKANL) 
of human catalase, which contains a peroxisomal sorting signal [16, 17], was replaced 
with that corresponding to each peptide.  
The plasmid constructs were linearized with SalI. P. pastoris yeast SMD1168 
was transformed by electroporation at 1.5 kV, 25 μF, 200 Ω. Minimal SD agar plates 
(2 % glucose, 0.5 % ammonium sulfate, 0.17 % yeast nitrogen base w/o amino acids 
and ammonium sulfate, 2 % agar) were used for the selection of P. pastoris 
transformants. Single colonies were picked and inoculated into 5 mL of YPD medium 
(1 % yeast extract, 2 % peptone, 2 % glucose) and grown at 30 °C in a bio-shaker with 
shaking at 250 rpm for 36 hr. A 2.5 mL aliquot of this suspension was inoculated to 500 
mL of YPD medium in 3 L flask, and the culture was grown for 24 hr. The cells were 
harvested with 2000 ×g centrifugation, and disrupted using a French Press at 2,000 psi. 
The clarified supernatants of cell lysates containing hCAT, hCAT-(RGD)3 or hCAT-R9 
were loaded onto a glutathione sepharose column (GE Healthcare, U.K.), and these 
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proteins were eluted by applying PreScission protease (GE Healthcare) in 50 mM 
Tris-HCl solution (pH 7.5). After concentration by ultrafiltration, the solvent of each 
elute was changed to water. The purified catalase derivatives were stored at -20 °C until 
use.  
 
Determination of catalase specific activity 
Protein concentration was quantified using a BCA Protein Assay Kit (Pierce, Rockford, 
IL, USA). Each catalase derivative (0.04 µg) was added to 25 mM phosphate buffer (pH 
7.0) containing 10 mM hydrogen peroxide, and the decomposition of hydrogen peroxide 
was monitored spectrophotometrically at 240 nm. Samples were used without any 
separation of active (heme-containing) and inactive (heme free) forms. Bovine liver 
catalase (50,400 U/mg protein; Sigma Aldlich, USA) was used as a standard. Each 
sample was measured in five replicates and their averages were employed.  
 
Measurement of circular dichroism 
Circular dichroism (CD) spectra were recorded using a JASCO-820 type 
spectropolarimeter (JASCO, Tokyo, Japan) at 4 °C. For calculation of the mean residue 
ellipticity [θ], the molecular mass of the catalase derivatives was assumed to be as 240 
kDa [8]. Far-UV (wavelength 200-250 nm) CD spectra were recorded at a protein 
concentration of 15 µM in Tris buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl).  
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Interaction of catalase derivatives with endothelial cells 
MAEC seeded on 24 well plates at a density of 1.0×105 cells/well were exposed to 
Medium 199 (Gibco, USA) containing one of the catalase derivatives at a concentration 
of 100 U/mL for 30 min at 4 °C or 37 °C. Then, the cells were washed with PBS and 
lysed with a lysis buffer (0.05 % Triton-X, 2 mM EDTA, 0.1 M Tris-HCl (pH 7.8)). The 
catalase activity of cell lysates was determined as described above. 
 
Intracellular ROS production under hypoxic conditions 
Intracellular ROS production was detected using CM-H2DCFDA (Invitrogen). MAEC 
were treated with 5 μM CM-H2DCFDA for 1 hr, and then were cultured under hypoxic 
conditions of 8 % oxygen. The fluorescence intensity was measured using a 1420 
Multilabel counter (PerkinEimer, USA) at an excitation wavelength of 485 nm and an 
emission wavelength of 530 nm. 
 
Measurement of luciferase activity 
Cells were lysed with the lysis buffer. Twenty microliters of the lysate was mixed with 
20 µL luciferase assay buffer (Picagene, Tokyo Ink, Tokyo, Japan) and the produced 
light was measured using a luminometer (Lumat LB 9507, EG&G Berthold, Bad 
Wildbad, Germany).  
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Cell adhesion assay 
To examine the effect of hydrogen peroxide on tumor cell adhesion, MAEC (1.0×105 
cells/well) were seeded on 24 well plates, added with hydrogen peroxide at a final 
concentration of 0 to 100 µM, and incubated for 6 h. Then, tumor cells (B16-BL6/Luc, 
LLC/Luc and colon26/Luc) at a density of 1.0×104 cells/well were added into each well 
containing the MAEC monolayer and incubated for 3 hr. Then, non-attached cells were 
washed out with PBS, and the remaining adherent cells were lysed with the lysis buffer. 
The luciferase activity of the lysates was measured as described above. Separately, 
MAEC were incubated under normoxic or hypoxic conditions for 6 hr. Then, tumor 
cells were added and their adhesion was examined as above. 
 
Transcription factor dependent reporter gene assay 
MAEC seeded on 24 well plates at a density of 1.0×105 cells/well were transfected with 
pHRE-Luc [18], pNF-κB-Luc, or pAP-1-Luc (Stratagene, La Jolla, CA, USA) using 
Lipofectamine 2000 as described above. After incubation under hypoxic or normoxic 
conditions for 6 hr, cells were lysed with the lysis buffer. The luciferase activity of the 
cell lysates was measured as described above.  
 
mRNA quantification 
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Total RNA was isolated from MAEC (2.0×105 cells) after incubation under hypoxic or 
normoxic conditions for 6 hr, and the mRNA expression of intercellular adhesion 
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in MAEC was 
estimated by real-time quantitative PCR using a LightCycler system (Roche Diagnostics, 
Mannheim, Germany). The mRNA expression of the target genes was normalized to the 
mRNA level of GAPDH. The primer sequences for RT-PCR were as follows, ICAM-1: 
forward 5’-GGGAATGTCACCAGGAAT-3’, reverse 
5’-TCCTGAGCCTTCTGTAACTTG-3’, VCAM-1: forward 
5’-CGGCATATACGAGTGTGAATC-3’, reverse 5’-ATCCCGATGGCAGGTATT-3’, 




Differences were statistically evaluated by one-way ANOVA followed by the 
Tukey-Kramer multiple comparison test, and the level of statistical significance was set 
at P<0.05. 
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Results 
Characterization of catalase derivatives 
Figure 1 shows the schematic representation of human catalase derivatives: hCAT, 
hCAT-(RGD)3 and hCAT-R9. Three constructs were expressed in P. pastoris, and 
purified as described in the Materials & Methods. Figure 2A shows the SDS-PAGE 
patterns of the human catalase derivatives. Each sample showed a single band of about 
60 kDa, indicating that the catalase derivatives were adequately purified. The far-CD 
spectra of hCAT-(RGD)3 and hCAT-R9 were similar to that of hCAT (Figure 2B), 
suggesting that the fusion of peptides hardly changed the secondary structure of human 
catalase. Figure 2C shows the time-dependent decomposition of hydrogen peroxide by 
the human catalase derivatives. The activities of hCAT, hCAT-(RGD)3 and hCAT-R9 
ware 20,000, 19,500 and 24,300 units/mg protein, respectively, indicating that the 
fusion hardly reduced the specific activity of human catalase. These results are in a 
good agreement with the previous finding that the modification of C-terminus of 
catalase hardly influenced its activity [19].  
  Next, the cellular association of catalase derivatives in MAEC was examined 
at 37 °C or 4 °C. The activity to degrade hydrogen peroxide in cellular fractions was 
used to estimate the amount of catalase derivatives associated with cells. Cells untreated 
with any catalase derivative had a very low activity of 0.85 ± 0.003 mU/105 cells. The 
activity of cells was increased to 94.2 ± 14.3 mU/105 cells when cells were incubated 
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with hCAT for 30 min at 37 °C, indicating hCAT is associated with cells. The activity of 
cells treated with hCAT-(RGD)3 or hCAT-R9 at 37 °C was significantly higher (217 ± 
31 and 261 ± 9 mU/105 cells, respectively) than that treated with hCAT. At 4 °C, a 
temperature at which internalization is essentially blocked, the activity of cells added 
with hCAT-R9 was significantly lower than that at 37 °C. On the other hand, the 
activities of cells added with hCAT or hCAT-(RGD)3 were not significantly different 
between the temperatures. These results suggest that the mechanisms of increased 
interaction of catalase derivatives with MAEC are different between hCAT-(RGD)3 and 
hCAT-R9.  
 
Effect of catalase derivatives on intracellular ROS generation in MAEC under hypoxic 
conditions 
The levels of intracellular ROS in MAEC were monitored using an ROS-sensitive probe. 
The fluorescence intensity increased significantly at 3 to 9 hr after exposure to hypoxia 
(Figure 4). Treatment of cells with hCAT before exposure to hypoxia slightly reduced 
the level of intracellular ROS in MAEC. Greater reduction was observed in MAEC 
treated with hCAT-(RGD)3 or hCAT-R9. The addition of 10 U/mL hCAT-(RGD)3 or 
hCAT-R9 was more effective in inhibiting the increase of the intracellular ROS than the 
addition of 100 U/mL hCAT (Figure 4). These results suggest that intracellular ROS 
generation in MAEC is induced soon after exposure to hypoxic stress, and can be 
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efficiently eliminated by catalase derivatives, especially by hCAT-(RGD)3 and 
hCAT-R9, in a dose-dependent manner.  
 
Adhesion of tumor cells to MAEC 
Next, we investigated whether hypoxia induces the adhesion of tumor cells to 
endothelial cells. Preincubation of MAEC with hydrogen peroxide significantly 
increased the adhesion of B16-BL6/Luc, colon26/Luc and LLC/Luc to MAEC (Figure 
5A). The number of cells bound to MAEC tended to increase depending on the 
concentration of hydrogen peroxide from 25 to 100 µM. Separately, MAEC were 
incubated under hypoxic or normoxic conditions, and then adhesion of tumor cells was 
examined. Again, an increased binding of tumor cells to MAEC was observed under 
hypoxic conditions compared with under normoxia (Figure 5B). Then, the effects of 
catalase derivatives on the hypoxia-induced adhesion of B16-BL6/Luc were examined 
by treating MAEC with catalase derivatives at a concentration of 1 or 100 U/mL. hCAT 
reduced the hypoxia-induced cell adhesion (Figure 6). Under the same condition, 
hCAT-(RGD)3 and hCAT-R9 showed a greater inhibitory effect on the hypoxia-induced 
tumor cell adhesion than hCAT. Significantly lower numbers of tumor cells were bound 
to MAEC treated with hCAT-(RGD)3 or hCAT-R9 (p<0.05 compared with the same 
concentration of hCAT). The effects of catalase derivatives on tumor cell adhesion 
under normoxic conditions were less apparent than those under hypoxia, suggesting that 
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catalase derivatives inhibit hypoxia-induced, hydrogen peroxide-mediated tumor cell 
adhesion under hypoxic conditions. 
 
Effect of catalase derivatives on transcription factor activity in MAEC under hypoxic 
conditions 
To investigate the mechanism of inhibitory effect of catalase derivatives on 
hypoxia-induced cell adhesion, the activity of transcription factors HIF-1, NF-κB and 
AP-1 was estimated using pHRE-Luc, pNF-κB-Luc and pAP-1-Luc, respectively. The 
addition of hydrogen peroxide to cells increased the luciferase activity in cells (data not 
shown), suggesting that the transcription factors are activated by the addition of 
hydrogen peroxide. Culture of MAEC under hypoxic conditions induced significant 
activation of HIF-1, NF-κB and AP-1 (Figure 7). The activation of HIF-1 and NF-κB 
was inhibited by catalase derivatives, especially by hCAT-(RGD)3 or hCAT-R9. 
Strikingly, pre-treatment of 100 U/mL of hCAT-R9 almost completely inhibited the 
activation of HIF-1, NF-κB and AP-1. In accordance with the results of tumor cell 
adhesion (Figure 6), the effects of catalase derivatives under normoxic conditions were 
less significant than those under hypoxic conditions. 
 
mRNA expression of adhesion molecules under hypoxic conditions 
Finally, the changes in mRNA level of cell adhesion molecules that have reported to be 
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induced by HIF-1 or NF-κB [20] were examined using RT-PCR. The expression of 
ICAM-1 was induced in MAEC under hypoxia (Figure 8), but that of VCAM-1 was 
hardly changed (data not shown). The increase in the mRNA level of ICAM-1 was 
reduced by all catalase derivatives examined. 
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Discussion 
Antioxidant enzymes including catalase have been believed to be promising therapeutic 
agents for a variety of human diseases related to oxidative stress, but the poor cell 
affinity of these enzymes has been a major obstacle in developing them as agents to 
protect cells and tissues from oxidative damage [8]. Recent studies have demonstrated 
that targeted or sustained delivery of bovine catalase by chemical modification is a 
therapeutic approach for ROS-mediated diseases, such as hepatic ischemia/reperfusion 
injury, cisplatin-induced nephrotoxicity and tumor metastasis [21-24]. However, 
chemical modification of protein, in general, has some disadvantages, such as 
productivity and uniformity of the products, compared with genetic modification from a 
viewpoint of clinical application. Furthermore, heterologous proteins, such as bovine 
catalase, can be immunogenic, so that the use of human catalase instead of bovine origin 
will reduce the possibility of antibody production after administration to patients [25]. 
In this study, we selected genetic engineering technique for modification of human 
catalase. 
Previous studies have reported that enhanced delivery of biologically active 
proteins to cells is possible by using peptides that have high affinity with cells, 
including RGD peptide and oligoarginine peptide [26-28]. RGD motifs are found in 
many extracellular matrix proteins, and are recognized by and bound to integrins, a 
family of cell adhesion receptors expressed on the surface of various cells [29]. On the 
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other hand, oligoarginine peptide is a short repeat of basic amino acid arginine, and it 
has been reported not only to bind to negatively charged cell membranes, but also to 
initiate macropinocytosis, a special form of endocytosis, which facilitates the 
internalization of surface-bound compounds [30]. In order to increase the affinity of 
catalase with endothelial cells, the C-terminus of catalase was fused with (RGD)3 
peptide or R9 peptide. It has been reported that three repeat of RGD has higher affinity 
with integrins than monomeric RGD [29, 31], so that the three repeat of the peptide was 
used for the construction of a catalase derivative containing RGD peptide. Both 
hCAT-(RGD)3 and hCAT-R9 showed an increased affinity for MAEC, but their cellular 
distribution was suggested to be different each other (Figure 3); hCAT-(RGD)3 could be 
bound to cell surface, whereas a part of hCAT-R9 was considered to be internalized 
during the 30-min incubation. R9 peptide fused to C-terminus of catalase might initiate 
the active cellular uptake mechanism as suggested in a previous report [30]. Although 
cellular distribution of these two types of catalase derivatives can be different each other, 
both eliminated intracellular ROS in MAEC, and inhibited the activation of HIF-1 and 
NF-κB under hypoxic condition. Because hCAT-(RGD)3 or hCAT-R9 was estimated 
more than 10 times effective than hCAT, the cytophilic nature of hCAT-(RGD)3 and 
hCAT-R9 is highly efficient for the removal of hydrogen peroxide generated in 
endothelial cells under hypoxic conditions. Two types of cytophilic catalase derivatives 
showed somewhat different intracellular distribution, but their inhibitory effects against 
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tumor cell adhesion were comparable. These results would be explained by the fact that 
hydrogen peroxide easily passes through cellular membranes. 
The present study demonstrated that the cytophilic catalase derivatives have 
high binding affinity to MAEC. However, these results do not mean that their inhibition 
of ROS-mediated events in MAEC is the only mechanism for inhibiting tumor cell 
adhesion. The intracellular ROS level in tumor cells would be increased by several 
mechanisms [32]. In addition, the interaction with MAEC would further increase the 
ROS level in tumor cells. Therefore, cytophilic catalase derivatives bound to MAEC 
would reduce the ROS level in tumor cells which are interacting with MAEC. 
In the design of catalase derivatives, the C-terminus of catalase was selected as 
the site for fusion with (RGD)3 peptide or R9 peptide. An X-ray structural analysis 
verified that the C-terminal region of human catalase is exposed on the surface of 
catalase molecule, and is distant from the active site [33]. In addition, human catalase 
contains a peroxisomal targeting signal in the C-terminal 11 amino acid sequence [16, 
17]. These findings suggest that a peptide fused at the C-terminus is extended outside 
the protein, and is able to interact with integrins or negatively charged compounds on 
cell surface, which does not interfere with enzymatic activity of catalase. In fact, the 
activity and secondary structure of human catalase derivatives were not different from 
those of wild-type human catalase. These properties were quite contrast to those of 
chemically modified bovine catalase with an overall positive charge [22]. 
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Tumor cells detached from primary tumors would be distributed to a variety of 
downstream organs via vascular or lymphatic pathways [34]. The adhesion to 
endothelial cells is the first step in the metastatic processes for tumor cells that have 
entered the blood circulation. It has been known that surgical removal of primary 
tumors increases the chance of tumor metastasis through a variety of mechanisms, 
including the release of tumor cells from primary tumors into circulation. 
Administration of cytophilic catalase derivatives before or during surgical removal of 
primary tumors could reduce the incidence of tumor metastasis through the inhibition of 
tumor cell adhesion as observed in the present studies using cultured cells. 
In conclusion, we have demonstrated that the fusion of (RGD)3 peptide or R9 
peptide to the C-terminus of catalase is an efficient method of increasing the cytophilic 
activity of catalase. Both hCAT-(RGD)3 and hCAT-R9 efficiently inhibited 
hypoxia-induced cell adhesion through controlling intracellular oxidative stress in 
MAEC under hypoxic conditions. These results suggest that newly designed cytophilic 
human catalase derivatives can be effective therapeutic agents for controlling 
hypoxia-induced tumor cell adhesion. 
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Figure legends 
Fig. 1: Schematic representation of human catalase derivatives.  
The DNA sequence corresponding to the C-terminal 11 amino acids 
(SHLAAREKANL) of human catalase, which contains peroxisomal targeting signals, 
was replaced with oligonucleotides coding RGDRGDRGD or RRRRRRRRR to obtain 
hCAT-(RGD)3 or hCAT-R9, respectively.  The fusion genes were inserted into the 
pNT401 expression vector and expressed in P. pastoris. 
 
Fig. 2: Characteristics of human catalase derivatives. 
 (A) Coomassie brilliant blue stained SDS-PAGE gel. Lane 1, Precision Protein 
Unstained Marker (Bio-Rad); Lane 2, soluble fraction of cell extracts from P. pastoris; 
Lane 3; purified extracts from P. pastoris using glutathione sepharose column. (B) 
Far-CD spectra of catalase derivatives. The protein concentration was 15 mM in Tris 
buffer. Key: (solid line), hCAT; (broken line), hCAT-(RGD)3; and (dotted line), 
hCAT-R9. (C) Time-dependent decomposition of hydrogen peroxide by catalase 
derivatives. The concentration of remaining hydrogen peroxide was measured 
spectrophotometrically at 240 nm. Key: (solid line), hCAT; (broken line), 
hCAT-(RGD)3; and (dotted line), hCAT-R9. 
 
Fig. 3: Catalase activity in MAEC after incubation with catalase derivatives. 
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 The enzymatic activity of catalase to degrade hydrogen peroxide in MAEC was 
measured. Key: (closed bar), hCAT; (hatched bar), hCAT-(RGD)3; (open bar), hCAT-R9. 
Results are expressed as the mean ± SD of three independent measurements. The 
catalase activity of untreated MAEC was 0.85 ± 0.003 mU/105 cells. *p<0.05 compared 
with the hCAT-treated group; † p<0.05 compared with the same sample at 37 °C. 
 
Fig. 4: Effect of catalase derivatives on ROS level in MAEC.  
Intracellular ROS level was monitored using an ROS-sensitive probe CM-H2DCFDA. 
After exposed to solution containing catalase derivatives for 30 min, MAEC were 
treated with 5 µM CM-H2DCFDA for 1 hr. Cells were cultured under hypoxic 
conditions (8 % oxygen). The fluorescence intensity was measured (excitation 485 nm, 
emission 530 nm), and the ratio to the initial value was plotted against the incubation 
period as relative fluorescent intensity. Key: (▼) normoxia, untreated; (▽) hypoxia, 
untreated; (●) hypoxia, hCAT; (△, ▲) hypoxia, hCAT-RGD; (□, ■) hypoxia, 
hCAT-R9. Concentrations of the derivatives added were 10 (open symbols) or 100 
U/mL (closed symbols). Results are expressed as the mean of 24 independent 
measurements. *p<0.05 compared with the hypoxia, untreated group (▽). † p<0.05 
compared with the 100 U/mL hCAT-treated group (●). 
 
Fig. 5: Effect of hydrogen peroxide or hypoxia on tumor cell adhesion to MAEC. 
 - 30 - 
(A) Effect of hydrogen peroxide on tumor cell adhesion to MAEC. MAEC were 
cultured in M199 containing 0-100 µM hydrogen peroxide for 6 hr, and then co-cultured 
with B16-BL6/Luc, LLC/Luc or Colon26/Luc for 3 hr. Cell adhesion was evaluated by 
measuring the luciferase activity of B16-BL6/Luc, LLC/Luc and Colon26/Luc cells 
bound to MAEC. Results are expressed as mean ± SD of three independent 
measurements. *p<0.05 compared with 0 µM hydrogen peroxide-treated group. (B) 
Effect of hypoxia on tumor cell adhesion to MAEC. Results are expressed as mean ± 
SD of three independent measurements. *p<0.05 compared with the normoxia group. 
Key: (Closed bar), B16-BL6/Luc; (hatched bar), LLC/Luc; (open bar), colon26/Luc. 
 
Fig. 6: Effect of catalase derivatives on adhesion of melanoma cells to MAEC. 
MAEC were exposed to solution containing catalase derivatives for 30 min. Cells were 
cultured in hypoxia for 6 hr, and then co-cultured with B16-BL6/Luc for 3 hr. Cell 
adhesion was evaluated by measuring the luciferase activity of B16-BL6/Luc cells 
bound to MAEC. Results are expressed as mean ± SD of three independent 
measurements. Key: (hatched bar), 1 U/mL; (open bar), 100 U/mL. *p<0.05 compared 
with the hypoxia, untreated group; #p<0.05 compared with the hCAT-treated group at 
the same dose; §p<0.05 compared with the normoxia, untreated group. 
 
Fig. 7: Effect of catalase derivatives on transcription factor activity in MAEC 
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under hypoxia. 
MAEC were transfected with pHRE-Luc (A), pNF-kB-Luc (B), or pAP-1-Luc (C). 
MAEC were exposed to solution containing catalase derivatives for 30 min. After 
incubation under hypoxic conditions for 6 hr, cells were lysed with lysis buffer. Each 
transcription factor activity was determined by measuring luciferase activity of the cell 
lysates. Results are normalized to the value of the normoxia, untreated group and are 
expressed as mean ± SD of three independent measurements. Key: (hatched bar), 1 
U/mL; (horizontal striped bar), 10 U/mL; (open bar), 100 U/mL. *p<0.05 compared 
with the hypoxia, untreated group; #p<0.05 compared with the hCAT-treated group at 
the same dose; §p<0.05 compared with the normoxia, untreated group; †p<0.05 
compared with the 100 U/mL hCAT-treated group. 
 
Fig. 8: Effect of catalase derivatives on mRNA expression of ICAM-1 in MAEC 
under hypoxic conditions. 
Total RNA was isolated from MAEC after incubation under hypoxic conditions for 6 hr, 
and the mRNA expression of ICAM-1 in MAEC was estimated by RT-PCR. The mRNA 
expression of ICAM-1 was normalized to that of GAPDH, and the value was then 
normalized to the value of the normoxia, untreated group. Results are expressed as 
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